Effective personalized neoantigen vaccine plus anti-PD-1 in a PD-1 blockade-resistant lung cancer patient

Gao, S; Wang, JQ; Zhu, ZZ; Fang, JM; Zhao, Y; Liu, ZQ; Qin, HL; Wei, YQ; Xu, H; Dan, X; Yang, L; Xu, Q

Xu, Q (通讯作者),Tongji Univ, Shanghai Peoples Hosp 10, Dept Oncol, Shanghai 200072, Peoples R China.;Xu, Q (通讯作者),Tongji Univ, Canc Ctr, Shanghai 200072, Peoples R China.;Yang, L (通讯作者),Sichuan Univ, State Key Lab Biotherapy, Dept Biotherapy, Chengdu 610041, Peoples R China.;Yang, L (通讯作者),Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Peoples R China.

IMMUNOTHERAPY, 2023; 15 (2): 57

Abstract

Plain language summaryImmunotherapy based on immune checkpoint inhibitors (ICIs) is very effective in lung cancer treatment. However, many patients wi......

Full Text Link